文献速递脑血管病

2020年COVID-19对急性缺血性卒中严重程度和死亡率的影响:来自2020年全国住院患者样本的结果

Effect of COVID-19 on Acute Ischemic Stroke Severity and Mortality in 2020: Results From the 2020 National Inpatient Sample.
PubMed 文献 · Stroke · 2023-04-06

该研究基于2016至2020年全国住院患者样本构建横断面队列,分析COVID-19对急性缺血性卒中结局的影响。结果显示2020年卒中死亡率显著高于2016-19年(7.3% vs 6.3%,P<0.001),合并COVID-19者NIHSS更高(均值9.7±9.1 vs 6.6±7.4,P<0.001);2020年4-12月西班牙裔和最低收入四分位人群的调整后院内卒中死亡风险增加最明显。

要点

  • 2020年急性缺血性卒中院内死亡率7.3%,高于2016-19年的6.3%(P<0.001)。
  • 合并COVID-19的卒中患者NIHSS均值9.7±9.1,高于无COVID-19者的6.6±7.4(P<0.001)。
  • 2020年4-12月西班牙裔和最低收入四分位人群的调整后院内卒中死亡风险增加最明显(分别为9.2% vs 5.8%和8.0% vs 6.0%,P<0.001)。

核心结论

  • 2020年美国院内卒中死亡率增加,归因于合并急性缺血性卒中与COVID-19,且后者卒中严重程度更高。
  • 2020年4-12月急性缺血性卒中死亡率增加在西班牙裔和家庭收入最低四分位人群中更为显著。

研究设计与样本

  • 横断面队列研究,使用2016至2020年全国住院患者样本中年龄≥18岁、诊断为缺血性卒中的非择期出院记录,并进行全国加权。
  • 暴露为COVID-19状态,主要结局为院内死亡,并按暴露状态报告美国国立卫生研究院卒中量表评分。
  • 最终分析采用全国加权逻辑回归和边际效应,比较2020年4月至12月与2019年同期。

主要发现

  • 2020年急性缺血性卒中死亡率显著高于2016-19年(7.3% vs 6.3%,P<0.001)。
  • 合并COVID-19者NIHSS均值9.7±9.1,高于无COVID-19者的6.6±7.4(P<0.001)。
  • 2020年无COVID-19的急性缺血性卒中患者死亡率仅略高于2016-2019年(6.6% vs 6.3%,P=0.001)。
  • 2020年4-12月与2019年同期相比,西班牙裔调整后院内卒中死亡风险为9.2% vs 5.8%(P<0.001)。
  • 2020年4-12月与2019年同期相比,最低收入四分位人群调整后院内卒中死亡风险为8.0% vs 6.0%(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a paucity of nationally representative data regarding the impact of COVID-19 on acute ischemic stroke (AIS) outcome. METHODS: We created a cross-sectional cohort of nationally weighted National Inpatient Sample nonelective hospital discharges aged ≥18 years with a diagnosis of ischemic stroke from 2016 to 2020. The outcome was in-hospital mortality and exposure was COVID-19 status. To understand the effect of COVID-19 on AIS severity, we report National Institutes of Health Stroke Scale by exposure status. In a final analysis, we used a nationally weighted logistic regression and marginal effects to compare April to December 2020 to the same period in 2019 to understand how the pandemic modified the effect of race and ethnicity and median household income on in-hospital AIS mortality. RESULTS: We observed significantly higher AIS mortality in 2020 than prior years (2020 versus 2016-19, 7.3% versus 6.3%, P<0.001) and higher National Institutes of Health Stroke Scale in those with COVID-19 than those without (mean: 9.7±9.1 versus 6.6±7.4, P<0.001), but patients with AIS without COVID in 2020 had only marginally higher mortality (2020 versus 2016-2019, 6.6% versus 6.3%, P=0.001). Comparing April to December 2020 to 2019, the adjusted risk of in-hospital AIS mortality was most notably increased in Hispanics (2020 versus 2019: 9.2% versus 5.8%, P<0.001) and the lowest quartile of income (2020 versus 2019: 8.0% versus 6.0%, P<0.001). CONCLUSIONS: In-hospital stroke mortality increased in 2020 in the United States because of comorbid AIS and COVID-19, which had higher stroke severity. The increase in AIS mortality during April-December 2020 was significantly more pronounced in Hispanics and those in the lowest quartile of household income.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. de Havenon A, Zhou LW, Yaghi S, et al. Effect of COVID-19 on Acute Ischemic Stroke Severity and Mortality in 2020: Results From the 2020 National Inpatient Sample. Stroke. 2023. PMID: 37021563. doi:10.1161/STROKEAHA.122.041929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。